University of Essex
↗Colchester, United Kingdom
The University of Essex is a leading public research university in the United Kingdom, recognized for its significant contributions to the life sciences, biotechnology, and pharmaceutical research. Its School of Life Sciences is a hub for interdisciplinary research, focusing on areas such as cancer biology, genomics, protein structure, and microbiology. The university operates the 'Knowledge Gateway' research and technology park, which fosters collaboration between academia and the private sector.
In the pharmaceutical and biotech space, the university is known for its translational research through the Essex Biomedical Sciences Centre (EBSC), a partnership with several NHS Trusts. Key research strengths include the development of artificial blood (HaemO2 project), cancer diagnostics, and the study of epigenetic markers in neurodegenerative diseases like Alzheimer's. The university is currently expanding its capabilities with the launch of the £2.5 million BioSTAR-Lab, dedicated to training and research in microbiology and molecular biology.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Academic Research & Tech Transfer
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$250M-$500M
Founded:1963
Ownership:nonprofit
Status:operating
FUNDING
Investors:Office for Students (OfS), Medical Research Council (MRC), Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, Royal Society
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Small molecule, Diagnostics, Synthetic biology, AI/Digital Health, Gene therapy, Protein engineering
Active Trials:5
Trial Phases:Phase 1: 2 | Phase 2: 2 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Knowledge Gateway, Metisox Ltd (Spin-out), HaemO2 (Project/Spin-out), Wivenhoe House Hotel
Key Partnerships:East Suffolk and North Essex NHS Foundation Trust (ESNEFT), University of Exeter (Alzheimer's research), University of Illinois (RIPE project), Francis Crick Institute (Summer training partnership)
COMPETITION
Position:Niche Player
Competitors:University of East Anglia, University of Cambridge, University College London (UCL), Imperial College London
LEADERSHIP
Key Executives:
Professor Frances Bowen - Vice-Chancellor
Professor Terry McGenity - Head of School of Life Sciences
Professor Chris Greer - Pro-Vice-Chancellor (Research)
Professor Silke Paulmann - Executive Dean (Faculty of Science and Health)
Scientific Founders:Professor Leo Schalkwyk (Genomics), Professor Tracy Lawson (Plant Biotech), Dr. Greg Brooke (Oncology)
Board Members:Chris Oldham (Chief Operating Officer), Andrew Keeble (Chief Financial Officer)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with University of Essex. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.